Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceuticals	2.06B	1.93B	1.54B	803.93M	32.32M
Total	2.06B	1.93B	1.54B	803.93M	32.32M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
The PRC	571.20M	92.65M	7.54M	56.49M	20.39M
The United States of America	1.31B	1.84B	1.53B	730.04M	-
Switzerland	168.69M	-	-	-	-
Other Countries	3.31M	-	4.73M	17.41M	11.94M
Total	2.06B	1.93B	1.54B	803.93M	32.32M

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error